Advancing Care in Vulvar Dermatoses: When and How to Use Systemic Agents
At the 2025 ODAC Dermatology Conference, Christina Kraus, MD, expanded on her earlier discussion of off-label topical approaches by surveying the landscape of systemic therapies for these challenging cases. Her lecture synthesized the latest evidence, highlighted patient-selection considerations, and introduced both established and emerging systemic agents—equippi …
At the 2025 ODAC Dermatology Conference, Christina Kraus, MD, expanded on her earlier discussion of off-label topical approaches by surveying the landscape of systemic therapies for these challenging cases. Her lecture synthesized the latest evidence, highlighted patient-selection considerations, and introduced both established and emerging systemic agents—equippi … Continue reading "Advancing Care in Vulvar Dermatoses: When and How to Use Systemic Agents"
At the 2025 ODAC Dermatology Conference, expert dermatologist Anthony Fernandez, MD, PhD presented a masterful talk on Advances in Psoriasis Treatment: Emerging Therapies and Future Directions. He explored emerging therapies and future directions in psoriasis management. Since 2004, the FDA has approved 14 novel systemic agents to treat moderate to severe psoriasis, 12 of which are biologics, an … 
As our world grows increasingly diverse, it is essential for physicians to enhance their cultural awareness and understanding of the unique needs of their patients. While medical education has made strides in incorporating lectures on cultural differences in patient care, true understanding comes from direct engagement. Immersing oneself in diverse communities through volunteerism provides invalua … 
At the 2025 ODAC Dermatology conference, Dr. Anthony Fernandez, MD, PhD gave an informative presentation titled, No-Brainer Approaches to Neutrophilic Dermatoses. His presentation focused on discussing the clinical presentation, differential diagnosis considerations, and treatment options of pyoderma gangrenosum and Sweet syndrome.
Pyoderma Gangrenosum (PG)
Pyoderma gangrenosum typically present … 